Moreover, while it is well-established that diabetes and obesity increase the risk of hormone-receptor positive breast cancer in postmenopausal women [20]–[22], there is now accumulating evidence that indicates an increased risk of hormone receptor negative breast cancer in women with metabolic syndrome [23] or obesity [20]. Here, NR4A1 is linked to metabolic syndrome.